563 ICT01, an anti-BTN3A mAb, and NL-201, an alpha-independent IL-2/IL-15 agonist, combine to elicit a potent anti-tumor response by synergistically stimulating Vg9Vd2 T cell activation and proliferation
oleh: Ryan Swanson, Aude de Gassart, Patrick Brune, Sophie Agaugué, Paul Frohna, Loui Madakamutil, Maelle Mairesse, Carl Walkey
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.